182 related articles for article (PubMed ID: 23067311)
21. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car.
Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I
Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and central nervous system effects of the novel dopamine D2 receptor antagonist JNJ-37822681.
te Beek ET; Moerland M; de Boer P; van Nueten L; de Kam ML; Burggraaf J; Cohen AF; van Gerven JM
J Psychopharmacol; 2012 Aug; 26(8):1119-27. PubMed ID: 21890591
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.
Liem-Moolenaar M; de Boer P; Timmers M; Schoemaker RC; van Hasselt JG; Schmidt S; van Gerven JM
Br J Clin Pharmacol; 2011 Jun; 71(6):886-98. PubMed ID: 21306419
[TBL] [Abstract][Full Text] [Related]
24. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR
Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216
[TBL] [Abstract][Full Text] [Related]
25. The sensitivity of pharmacodynamic tests for the central nervous system effects of drugs on the effects of sleep deprivation.
van Steveninck AL; van Berckel BN; Schoemaker RC; Breimer DD; van Gerven JM; Cohen AF
J Psychopharmacol; 1999; 13(1):10-7. PubMed ID: 10221355
[TBL] [Abstract][Full Text] [Related]
26. Neurokinin release in the rat nucleus of the solitary tract via NMDA and AMPA receptors.
Colin I; Blondeau C; Baude A
Neuroscience; 2002; 115(4):1023-33. PubMed ID: 12453476
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in the guinea pig.
Goldhill J; Angel I
Eur J Pharmacol; 1998 Dec; 363(2-3):161-8. PubMed ID: 9881585
[TBL] [Abstract][Full Text] [Related]
29. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men.
Anderson RA; Cormier J; Thieroff-Ekerdt R; Boyce M; van den Berg F; Grau D; Turnquist D; Corzo D; Graham P
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4857-65. PubMed ID: 32946574
[TBL] [Abstract][Full Text] [Related]
31. Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials.
García-Gea C; Martínez J; Ballester MR; Gich I; Valiente R; Antonijoan RM
Hum Psychopharmacol; 2014 Mar; 29(2):120-32. PubMed ID: 24395298
[TBL] [Abstract][Full Text] [Related]
32. Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands.
Peters JU; Hoffmann T; Schnider P; Stadler H; Koblet A; Alker A; Poli SM; Ballard TM; Spooren W; Steward L; Sleight AJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3405-8. PubMed ID: 20430616
[TBL] [Abstract][Full Text] [Related]
33. The unpredicted high affinities of a large number of naturally occurring tachykinins for chimeric NK1/NK3 receptors suggest a role for an inhibitory domain in determining receptor specificity.
Tian Y; Wu LH; Oxender DL; Chung FZ
J Biol Chem; 1996 Aug; 271(34):20250-7. PubMed ID: 8702757
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
35. Tachykinin NK1 and NK3 receptors in the prefrontal cortex of the human brain.
Tooney PA; Au GG; Chahl LA
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):947-9. PubMed ID: 11071316
[TBL] [Abstract][Full Text] [Related]
36. Effects of desloratadine and alcohol coadministration on psychomotor performance.
Scharf M; Berkowitz D
Curr Med Res Opin; 2007 Feb; 23(2):313-21. PubMed ID: 17288686
[TBL] [Abstract][Full Text] [Related]
37. Developmental expression of neurokinin-1 and neurokinin-3 receptors in the rat retina.
Casini G; Brecha NC; Bosco L; Rickman DW
J Comp Neurol; 2000 May; 421(2):275-87. PubMed ID: 10813787
[TBL] [Abstract][Full Text] [Related]
38. Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: A single ascending-dose study.
Eldon MA; Kugler AR; Medve RA; Bui K; Butler K; Sostek M
Clin Pharmacol Drug Dev; 2015 Nov; 4(6):434-41. PubMed ID: 27137715
[TBL] [Abstract][Full Text] [Related]
39. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
40. Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina.
Oyamada H; Takatsuji K; Senba E; Mantyh PW; Tohyama M
Brain Res Dev Brain Res; 1999 Oct; 117(1):59-70. PubMed ID: 10536233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
